Comparing the H1 hip implant with total hip replacement for hip arthritis
Compares a hip resurfacing implant with total hip replacement in people with hip arthritis.
Key facts
- Who runs it
- Embody Orthopaedic Limited
- Where
- Bournemouth, Coventry, and Truro, United KingdomSee the 3 sites
- Trial code
- Registry title
- The ACTIVE Trial: A Prospective Randomised Control Trial Of The H1 Implant Versus Total Hip Replacement
- Status
- Recruiting
- People taking part
- 200 people, planned
- Started
- 21 Jul 2026
- Expected to end
- 31 Dec 2036
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- The H1 Implant
- Cementless total hip replacement
- Record updated
- 13 August 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for people with hip arthritis who need a first hip replacement on one side. They will get either a new hip resurfacing (the H1 Implant) or a total hip replacement.
- Age
- The record gives no age range. People whose bones are not fully grown cannot join.
- Sex
- All sexes can join.
- Disease stage
- Hip arthritis needing a first replacement of one hip. This can be primary osteoarthritis, osteoarthritis after e.g. injury, avascular necrosis (bone death) or hip dysplasia, or inflammatory arthritis.
- Earlier treatment
- People who already have another lower limb joint replacement or joint fusion cannot join.
Main reasons for not taking part
- BMI greater than 40 kg/m².
- Active infection or sepsis, treated or untreated.
- Weak bone at the hip (>1/3 necrosis of the femoral head or large and multiple cysts), or severe osteopenia or osteoporosis (t-score < -2.5).
- Needing another lower limb joint replacement or fusion within 2 years.
- Unable to give consent, or unable to understand the local language.
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Patient requires unilateral primary hip arthroplasty due to primary osteoarthritis, osteoarthritis secondary to e.g. trauma, avascular necrosis or developmental hip dysplasia, or inflammatory arthritis
- Patient is willing to comply with study requirements
- Patient plans to be available through 10 years postoperative follow-up
Who cannot take part
- Patient has active infection or sepsis (treated or untreated)
- Patient has a BMI greater than 40 kg/m²
- Patient has insufficient bone stock at the hip (>1/3 necrosis of the femoral head or large and multiple cysts) or in general as in severe osteopenia or osteoporosis (t-score < -2.5 as measured with BMD)
- Patient is not skeletally mature
- Patient meets the contraindication criteria of the control device
- Patient already has another lower limb arthroplasty or arthrodesis or will require a further lower limb arthroplasty or arthrodesis within the subsequent 2 years
- Patient lacks capacity to consent
- Patient is unable to understand the native language of the country where their procedure is taking place
Where in United Kingdom
- University Hospitals Dorset NHS Foundation TrustBournemouth, United KingdomContact: Camilla Halewood, PhDTaking people
- University Hospitals Coventry & WarwickshireCoventry, United KingdomContact: Camilla Halewood, PhDTaking people
- Royal Cornwall Hospitals NHS TrustTruro, United KingdomContact: Camilla Halewood, PhDTaking people
About the trial
What the trial wants to find out
The goal of this randomised controlled trial is to compare the success of two types of hip replacement in patients with hip arthritis. The main question it aims to answer is whether a new type of hip replacement (called a hip resurfacing) can be as successful as an existing hip replacement (called a total hip replacement). Patients will be given either the new hip resurfacing or the existing total hip replacement and researchers will compare their function, complication rate and physical activity.
The 2 groups in the trial
- The H1 ImplantTreatment being tested
Cementless, ceramic-on-ceramic hip resurfacing arthroplasty (HRA) device.
- Cementless total hip replacementExisting treatment, for comparison
Cementless ceramic-on-poly or ceramic-on-ceramic total hip replacement
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- The ACTIVE Trial: A Prospective Randomised Control Trial Of The H1 Implant Versus Total Hip Replacement
- Plain-language title
- Comparing the H1 hip implant with total hip replacement for hip arthritisGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 13 August 2026